Analysis of the promoter region of human placenta-specific DSCR4 gene.

The gene DSCR4 locates in the band q22.2 of human chromosome 21 and encodes a protein of 118 amino acids. Expression of DSCR4 is restricted to human placenta and placental choriocarcinoma cell lines BeWo and JEG3. The 5'-RACE method using RNA from human placenta indicated the major transcription start site at 93 nt upstream (nt -93) of the initiation codon. Transfection assay using a series of deletion constructs of the 5'-flanking region fused to the luciferase reporter gene identified three positive regions nt -2200 to -2088, nt -2064 to -1924, nt -810 to -632 and two negative regions nt -1923 to -1740, nt -631 to -425. The computer analysis predicted the presence of several cis-elements in these regions and the promoter assay using various mutants of consensus sequence identified two distinct cis-elements for OLF-1 and E47. The electrophoretic mobility shift assay (EMSA) using the extracts of DSCR4-expressing cells confirmed the binding of certain protein factors to these cis-elements. In fact, OLF-1-like transcription factor, EBF-3 and EBF-4 were detected in the DSCR4-expressing cell lines and human placenta. Based on these data, we postulated that transcription of DSCR4 gene is regulated positively by binding of OLF-1-like transcription factor and negatively by binding of E47-like transcription factor.

[1]  D. Luton,et al.  Impact of trisomy 21 on human trophoblast behaviour and hormonal function. , 2004, Placenta.

[2]  K. Spencer.  What is the true fetal loss rate in pregnancies affected by trisomy 21 and how does this influence whether first trimester detection rates are superior to those in the second trimester? , 2001, Prenatal diagnosis.

[3]  S. Minoshima,et al.  Molecular mechanisms of human single-minded 2 (SIM2) gene expression: identification of a promoter site in the SIM2 genomic sequence. , 2001, Gene.

[4]  N. Wald,et al.  Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. , 1999, The New England journal of medicine.

[5]  N. Wald,et al.  Fetal loss in Down syndrome pregnancies , 1999, Prenatal diagnosis.

[6]  A. G. Betz,et al.  Cloning of a Novel Olf-1/EBF-like Gene, O/E-4, by Degenerate Oligo-based Direct Selection , 2002, Molecular and Cellular Neuroscience.

[7]  Colin N. Dewey,et al.  Initial sequencing and comparative analysis of the mouse genome. , 2002 .

[8]  C. A. Dunn,et al.  Transcription of two human genes from a bidirectional endogenous retrovirus promoter. , 2006, Gene.

[9]  J. Smyth,et al.  Progress in Clinical and Biological Research , 1979 .

[10]  R. Grosschedl,et al.  Purification of early-B-cell factor and characterization of its DNA-binding specificity , 1993, Molecular and cellular biology.

[11]  M. Hattori,et al.  Identification of two novel primate-specific genes in DSCR. , 2002, DNA research : an international journal for rapid publication of reports on genes and genomes.

[12]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[13]  K. Nicolaides,et al.  Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies. , 2000, Placenta.

[14]  J. Delabar,et al.  Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21 , 1993, European journal of human genetics : EJHG.

[15]  S. Handwerger,et al.  A Placenta-Specific Enhancer of the Human Syncytin Gene1 , 2005, Biology of reproduction.

[16]  J. Mccoy,et al.  Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis , 2000, Nature.

[17]  R. Y. Tsai,et al.  The Characterization of the Olf-1/EBF-Like HLH Transcription Factor Family: Implications in Olfactory Gene Regulation and Neuronal Development , 1997, The Journal of Neuroscience.

[18]  S. Fisher,et al.  Trisomy 21 is associated with variable defects in cytotrophoblast differentiation along the invasive pathway , 2004, American journal of medical genetics. Part A.

[19]  M. Hattori,et al.  The DNA sequence of human chromosome 21 , 2000, Nature.

[20]  R. Reeves,et al.  Understanding the Basis for Down Syndrome Phenotypes , 2006, PLoS genetics.

[21]  P. Husslein,et al.  Tissue-specific and ubiquitous basic helix-loop-helix transcription factors in human placental trophoblasts. , 2005, Placenta.

[22]  F. Guillemot.  Vertebrate bHLH genes and the determination of neuronal fates. , 1999, Experimental cell research.

[23]  D. Luton,et al.  Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy. , 2004, The Journal of clinical endocrinology and metabolism.

[24]  M. Hattori,et al.  A novel gene isolated from human placenta located in Down syndrome critical region on chromosome 21. , 1997, DNA research : an international journal for rapid publication of reports on genes and genomes.

[25]  D. Luton,et al.  Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down's syndrome. , 2001, Placenta.

[26]  N. Bannert,et al.  Retroelements and the human genome: New perspectives on an old relation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Luton,et al.  Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. , 2000, The Journal of clinical endocrinology and metabolism.